These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 30947911)

  • 1. Cardiac Phenotypes, Genetics, and Risks in Familial Noncompaction Cardiomyopathy.
    van Waning JI; Caliskan K; Michels M; Schinkel AFL; Hirsch A; Dalinghaus M; Hoedemaekers YM; Wessels MW; IJpma AS; Hofstra RMW; van Slegtenhorst MA; Majoor-Krakauer D
    J Am Coll Cardiol; 2019 Apr; 73(13):1601-1611. PubMed ID: 30947911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies: Results From a Dutch Multicenter Cohort Study.
    Jansen M; de Brouwer R; Hassanzada F; Schoemaker AE; Schmidt AF; Kooijman-Reumerman MD; Bracun V; Slieker MG; Dooijes D; Vermeer AMC; Wilde AAM; Amin AS; Lekanne Deprez RH; Herkert JC; Christiaans I; de Boer RA; Jongbloed JDH; van Tintelen JP; Asselbergs FW; Baas AF
    JACC Heart Fail; 2024 Jan; 12(1):134-147. PubMed ID: 37565978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Review of Genotype-Phenotype Correlations in Noncompaction Cardiomyopathy.
    van Waning JI; Moesker J; Heijsman D; Boersma E; Majoor-Krakauer D
    J Am Heart Assoc; 2019 Dec; 8(23):e012993. PubMed ID: 31771441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics, Clinical Features, and Long-Term Outcome of Noncompaction Cardiomyopathy.
    van Waning JI; Caliskan K; Hoedemaekers YM; van Spaendonck-Zwarts KY; Baas AF; Boekholdt SM; van Melle JP; Teske AJ; Asselbergs FW; Backx APCM; du Marchie Sarvaas GJ; Dalinghaus M; Breur JMPJ; Linschoten MPM; Verlooij LA; Kardys I; Dooijes D; Lekanne Deprez RH; IJpma AS; van den Berg MP; Hofstra RMW; van Slegtenhorst MA; Jongbloed JDH; Majoor-Krakauer D
    J Am Coll Cardiol; 2018 Feb; 71(7):711-722. PubMed ID: 29447731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
    Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
    Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac beta-myosin heavy chain defects in two families with non-compaction cardiomyopathy: linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies.
    Hoedemaekers YM; Caliskan K; Majoor-Krakauer D; van de Laar I; Michels M; Witsenburg M; ten Cate FJ; Simoons ML; Dooijes D
    Eur Heart J; 2007 Nov; 28(22):2732-7. PubMed ID: 17947214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage.
    Viswanathan SK; Sanders HK; McNamara JW; Jagadeesan A; Jahangir A; Tajik AJ; Sadayappan S
    PLoS One; 2017; 12(11):e0187948. PubMed ID: 29121657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biallelic mutation in MYH7 and MYBPC3 leads to severe cardiomyopathy with left ventricular noncompaction phenotype.
    Kolokotronis K; Kühnisch J; Klopocki E; Dartsch J; Rost S; Huculak C; Mearini G; Störk S; Carrier L; Klaassen S; Gerull B
    Hum Mutat; 2019 Aug; 40(8):1101-1114. PubMed ID: 30924982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy.
    Velicki L; Jakovljevic DG; Preveden A; Golubovic M; Bjelobrk M; Ilic A; Stojsic S; Barlocco F; Tafelmeier M; Okwose N; Tesic M; Brennan P; Popovic D; Ristic A; MacGowan GA; Filipovic N; Maier LS; Olivotto I
    BMC Cardiovasc Disord; 2020 Dec; 20(1):516. PubMed ID: 33297970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features, spectrum of causal genetic mutations and outcome of hypertrophic cardiomyopathy in South Africans.
    Ntusi NA; Shaboodien G; Badri M; Gumedze F; Mayosi BM
    Cardiovasc J Afr; 2016; 27(3):152-158. PubMed ID: 27841901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
    Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
    Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype phenotype correlations of cardiac beta-myosin heavy chain mutations in Indian patients with hypertrophic and dilated cardiomyopathy.
    Rai TS; Ahmad S; Bahl A; Ahuja M; Ahluwalia TS; Singh B; Talwar KK; Khullar M
    Mol Cell Biochem; 2009 Jan; 321(1-2):189-96. PubMed ID: 18953637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic basis of cardiomyopathy and the genotypes involved in prognosis and left ventricular reverse remodeling.
    Tobita T; Nomura S; Fujita T; Morita H; Asano Y; Onoue K; Ito M; Imai Y; Suzuki A; Ko T; Satoh M; Fujita K; Naito AT; Furutani Y; Toko H; Harada M; Amiya E; Hatano M; Takimoto E; Shiga T; Nakanishi T; Sakata Y; Ono M; Saito Y; Takashima S; Hagiwara N; Aburatani H; Komuro I
    Sci Rep; 2018 Jan; 8(1):1998. PubMed ID: 29386531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy.
    Weissler-Snir A; Hindieh W; Gruner C; Fourey D; Appelbaum E; Rowin E; Care M; Lesser JR; Haas TS; Udelson JE; Manning WJ; Olivotto I; Tomberli B; Maron BJ; Maron MS; Crean AM; Rakowski H; Chan RH
    Circ Cardiovasc Imaging; 2017 Feb; 10(2):. PubMed ID: 28193612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of mutations in symptomatic patients with hypertrophic cardiomyopathy in Taiwan.
    Chiou KR; Chu CT; Charng MJ
    J Cardiol; 2015 Mar; 65(3):250-6. PubMed ID: 25086479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics and Long-Term Outcome of Hypertrophic Cardiomyopathy in Individuals With a MYBPC3 (Myosin-Binding Protein C) Founder Mutation.
    van Velzen HG; Schinkel AFL; Oldenburg RA; van Slegtenhorst MA; Frohn-Mulder IME; van der Velden J; Michels M
    Circ Cardiovasc Genet; 2017 Aug; 10(4):. PubMed ID: 28794111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of inherited cardiomyopathy using next generation semiconductor sequencing technologies.
    Lu C; Wu W; Liu F; Yang K; Li J; Liu Y; Wang R; Si N; Gao P; Liu Y; Zhang S; Zhang X
    J Transl Med; 2018 Aug; 16(1):241. PubMed ID: 30165862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy.
    Chida A; Inai K; Sato H; Shimada E; Nishizawa T; Shimada M; Furutani M; Furutani Y; Kawamura Y; Sugimoto M; Ishihara J; Fujiwara M; Soga T; Kawana M; Fuji S; Tateno S; Kuraishi K; Kogaki S; Nishimura M; Ayusawa M; Ichida F; Yamazawa H; Matsuoka R; Nonoyama S; Nakanishi T
    Heart Vessels; 2017 Jun; 32(6):700-707. PubMed ID: 27885498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy.
    Núñez L; Gimeno-Blanes JR; Rodríguez-García MI; Monserrat L; Zorio E; Coats C; McGregor CG; Hernandez del Rincón JP; Castro-Beiras A; Hermida-Prieto M
    Circ J; 2013; 77(9):2358-65. PubMed ID: 23782526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in sarcomere protein genes in left ventricular noncompaction.
    Klaassen S; Probst S; Oechslin E; Gerull B; Krings G; Schuler P; Greutmann M; Hürlimann D; Yegitbasi M; Pons L; Gramlich M; Drenckhahn JD; Heuser A; Berger F; Jenni R; Thierfelder L
    Circulation; 2008 Jun; 117(22):2893-901. PubMed ID: 18506004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.